Angio-Long Noncoding RNA MALAT1 Gene Variants in Ovarian Cancer
The genotyping of long non-coding RNA (lncRNA)-related single-nucleotide polymorphisms (SNPs) could be associated with cancer risk and/or progression. This study aimed to analyze the angiogenesis-related lncRNAs MALAT1 (rs3200401) and MIAT (rs1061540) variants in patients with ovarian cancer (OC) us...
Gespeichert in:
Veröffentlicht in: | Epigenomes 2024-01, Vol.8 (1) |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 1 |
container_start_page | |
container_title | Epigenomes |
container_volume | 8 |
creator | Fawzy, Manal S Ibrahiem, Afaf T Osman, Dalia Mohammad Almars, Amany I Alshammari, Maali Subhi Almazyad, Layan Tariq Almatrafi, Noof Daif Allah Almazyad, Renad Tariq Toraih, Eman A |
description | The genotyping of long non-coding RNA (lncRNA)-related single-nucleotide polymorphisms (SNPs) could be associated with cancer risk and/or progression. This study aimed to analyze the angiogenesis-related lncRNAs MALAT1 (rs3200401) and MIAT (rs1061540) variants in patients with ovarian cancer (OC) using “Real-Time allelic discrimination polymerase chain reaction” in 182 formalin-fixed paraffin-embedded (FFPE) samples of benign, borderline, and primary malignant ovarian tissues. Differences in the genotype frequencies between low-grade ovarian epithelial tumors (benign/borderline) and malignant tumors and between high-grade malignant epithelial tumors and malignant epithelial tumors other than high-grade serous carcinomas were compared. Odds ratios (ORs)/95% confidence intervals were calculated as measures of the association strength. Additionally, associations of the genotypes with the available pathological data were analyzed. The heterozygosity of MALAT1 rs3200401 was the most common genotype (47.8%), followed by C/C (36.3%). Comparing the study groups, no significant differences were observed regarding this variant. In contrast, the malignant epithelial tumors had a higher frequency of the MIAT rs1061540 C/C genotype compared to the low-grade epithelial tumor cohorts (56.7% vs. 37.6, p = 0.031). The same genotype was significantly higher in high-grade serous carcinoma than its counterparts (69.4% vs. 43.8%, p = 0.038). Multivariate Cox regression analysis showed that the age at diagnosis was significantly associated with the risk of OC development. In contrast, the MIAT T/T genotype was associated with a low risk of malignant epithelial tumors under the homozygote comparison model (OR = 0.37 (0.16–0.83), p = 0.017). Also, MIAT T allele carriers were less likely to develop high-grade serous carcinoma under heterozygote (CT vs. CC; OR = 0.33 (0.12–0.88), p = 0.027) and homozygote (TT vs. CC; OR = 0.26 (0.07–0.90), p = 0.034) comparison models. In conclusion, our data provide novel evidence for a potential association between the lncRNA MIAT rs1061540 and the malignant condition of ovarian cancer, suggesting the involvement of such lncRNAs in OC development. |
doi_str_mv | 10.3390/epigenomes8010005 |
format | Article |
fullrecord | <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A788246745</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A788246745</galeid><sourcerecordid>A788246745</sourcerecordid><originalsourceid>FETCH-LOGICAL-g675-8467cd5d4b043e56684d28be58bd2376de075da2d9c0387159cd14965bb2ed7d3</originalsourceid><addsrcrecordid>eNptj01LAzEQhoMoWGp_gLeA563ZfO9JQtEqrC3I4rVkk9kl0k1kU_z9BvXQg8xh3hmeeWcGoduarBlryD18hhFimiBrUhNCxAVaUKJExaUQl2f6Gq1y_igEJVppTRbowcQxpKpNccS7FF3yoai3ncGvpjVdjbcQAb_bOdh4yjhEvP_6KfDGRgfzDboa7DHD6i8vUff02G2eq3a_fdmYthpl2a25VM4Lz3vCGQgpNfdU9yB07ylT0kO50FvqG0eYVrVonK95I0XfU_DKsyW6-7Ud7REOIQ7pNFs3hewOpjxCiz8XhVr_Q5XwMAWXIgyh9M8GvgFxfVqV</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Angio-Long Noncoding RNA MALAT1 Gene Variants in Ovarian Cancer</title><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central Open Access</source><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Fawzy, Manal S ; Ibrahiem, Afaf T ; Osman, Dalia Mohammad ; Almars, Amany I ; Alshammari, Maali Subhi ; Almazyad, Layan Tariq ; Almatrafi, Noof Daif Allah ; Almazyad, Renad Tariq ; Toraih, Eman A</creator><creatorcontrib>Fawzy, Manal S ; Ibrahiem, Afaf T ; Osman, Dalia Mohammad ; Almars, Amany I ; Alshammari, Maali Subhi ; Almazyad, Layan Tariq ; Almatrafi, Noof Daif Allah ; Almazyad, Renad Tariq ; Toraih, Eman A</creatorcontrib><description>The genotyping of long non-coding RNA (lncRNA)-related single-nucleotide polymorphisms (SNPs) could be associated with cancer risk and/or progression. This study aimed to analyze the angiogenesis-related lncRNAs MALAT1 (rs3200401) and MIAT (rs1061540) variants in patients with ovarian cancer (OC) using “Real-Time allelic discrimination polymerase chain reaction” in 182 formalin-fixed paraffin-embedded (FFPE) samples of benign, borderline, and primary malignant ovarian tissues. Differences in the genotype frequencies between low-grade ovarian epithelial tumors (benign/borderline) and malignant tumors and between high-grade malignant epithelial tumors and malignant epithelial tumors other than high-grade serous carcinomas were compared. Odds ratios (ORs)/95% confidence intervals were calculated as measures of the association strength. Additionally, associations of the genotypes with the available pathological data were analyzed. The heterozygosity of MALAT1 rs3200401 was the most common genotype (47.8%), followed by C/C (36.3%). Comparing the study groups, no significant differences were observed regarding this variant. In contrast, the malignant epithelial tumors had a higher frequency of the MIAT rs1061540 C/C genotype compared to the low-grade epithelial tumor cohorts (56.7% vs. 37.6, p = 0.031). The same genotype was significantly higher in high-grade serous carcinoma than its counterparts (69.4% vs. 43.8%, p = 0.038). Multivariate Cox regression analysis showed that the age at diagnosis was significantly associated with the risk of OC development. In contrast, the MIAT T/T genotype was associated with a low risk of malignant epithelial tumors under the homozygote comparison model (OR = 0.37 (0.16–0.83), p = 0.017). Also, MIAT T allele carriers were less likely to develop high-grade serous carcinoma under heterozygote (CT vs. CC; OR = 0.33 (0.12–0.88), p = 0.027) and homozygote (TT vs. CC; OR = 0.26 (0.07–0.90), p = 0.034) comparison models. In conclusion, our data provide novel evidence for a potential association between the lncRNA MIAT rs1061540 and the malignant condition of ovarian cancer, suggesting the involvement of such lncRNAs in OC development.</description><identifier>ISSN: 2075-4655</identifier><identifier>EISSN: 2075-4655</identifier><identifier>DOI: 10.3390/epigenomes8010005</identifier><language>eng</language><publisher>MDPI AG</publisher><subject>Analysis ; Antisense RNA ; Cancer ; Genetic aspects ; Ovarian cancer ; Physiological aspects</subject><ispartof>Epigenomes, 2024-01, Vol.8 (1)</ispartof><rights>COPYRIGHT 2024 MDPI AG</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,864,27924,27925</link.rule.ids></links><search><creatorcontrib>Fawzy, Manal S</creatorcontrib><creatorcontrib>Ibrahiem, Afaf T</creatorcontrib><creatorcontrib>Osman, Dalia Mohammad</creatorcontrib><creatorcontrib>Almars, Amany I</creatorcontrib><creatorcontrib>Alshammari, Maali Subhi</creatorcontrib><creatorcontrib>Almazyad, Layan Tariq</creatorcontrib><creatorcontrib>Almatrafi, Noof Daif Allah</creatorcontrib><creatorcontrib>Almazyad, Renad Tariq</creatorcontrib><creatorcontrib>Toraih, Eman A</creatorcontrib><title>Angio-Long Noncoding RNA MALAT1 Gene Variants in Ovarian Cancer</title><title>Epigenomes</title><description>The genotyping of long non-coding RNA (lncRNA)-related single-nucleotide polymorphisms (SNPs) could be associated with cancer risk and/or progression. This study aimed to analyze the angiogenesis-related lncRNAs MALAT1 (rs3200401) and MIAT (rs1061540) variants in patients with ovarian cancer (OC) using “Real-Time allelic discrimination polymerase chain reaction” in 182 formalin-fixed paraffin-embedded (FFPE) samples of benign, borderline, and primary malignant ovarian tissues. Differences in the genotype frequencies between low-grade ovarian epithelial tumors (benign/borderline) and malignant tumors and between high-grade malignant epithelial tumors and malignant epithelial tumors other than high-grade serous carcinomas were compared. Odds ratios (ORs)/95% confidence intervals were calculated as measures of the association strength. Additionally, associations of the genotypes with the available pathological data were analyzed. The heterozygosity of MALAT1 rs3200401 was the most common genotype (47.8%), followed by C/C (36.3%). Comparing the study groups, no significant differences were observed regarding this variant. In contrast, the malignant epithelial tumors had a higher frequency of the MIAT rs1061540 C/C genotype compared to the low-grade epithelial tumor cohorts (56.7% vs. 37.6, p = 0.031). The same genotype was significantly higher in high-grade serous carcinoma than its counterparts (69.4% vs. 43.8%, p = 0.038). Multivariate Cox regression analysis showed that the age at diagnosis was significantly associated with the risk of OC development. In contrast, the MIAT T/T genotype was associated with a low risk of malignant epithelial tumors under the homozygote comparison model (OR = 0.37 (0.16–0.83), p = 0.017). Also, MIAT T allele carriers were less likely to develop high-grade serous carcinoma under heterozygote (CT vs. CC; OR = 0.33 (0.12–0.88), p = 0.027) and homozygote (TT vs. CC; OR = 0.26 (0.07–0.90), p = 0.034) comparison models. In conclusion, our data provide novel evidence for a potential association between the lncRNA MIAT rs1061540 and the malignant condition of ovarian cancer, suggesting the involvement of such lncRNAs in OC development.</description><subject>Analysis</subject><subject>Antisense RNA</subject><subject>Cancer</subject><subject>Genetic aspects</subject><subject>Ovarian cancer</subject><subject>Physiological aspects</subject><issn>2075-4655</issn><issn>2075-4655</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNptj01LAzEQhoMoWGp_gLeA563ZfO9JQtEqrC3I4rVkk9kl0k1kU_z9BvXQg8xh3hmeeWcGoduarBlryD18hhFimiBrUhNCxAVaUKJExaUQl2f6Gq1y_igEJVppTRbowcQxpKpNccS7FF3yoai3ncGvpjVdjbcQAb_bOdh4yjhEvP_6KfDGRgfzDboa7DHD6i8vUff02G2eq3a_fdmYthpl2a25VM4Lz3vCGQgpNfdU9yB07ylT0kO50FvqG0eYVrVonK95I0XfU_DKsyW6-7Ud7REOIQ7pNFs3hewOpjxCiz8XhVr_Q5XwMAWXIgyh9M8GvgFxfVqV</recordid><startdate>20240101</startdate><enddate>20240101</enddate><creator>Fawzy, Manal S</creator><creator>Ibrahiem, Afaf T</creator><creator>Osman, Dalia Mohammad</creator><creator>Almars, Amany I</creator><creator>Alshammari, Maali Subhi</creator><creator>Almazyad, Layan Tariq</creator><creator>Almatrafi, Noof Daif Allah</creator><creator>Almazyad, Renad Tariq</creator><creator>Toraih, Eman A</creator><general>MDPI AG</general><scope/></search><sort><creationdate>20240101</creationdate><title>Angio-Long Noncoding RNA MALAT1 Gene Variants in Ovarian Cancer</title><author>Fawzy, Manal S ; Ibrahiem, Afaf T ; Osman, Dalia Mohammad ; Almars, Amany I ; Alshammari, Maali Subhi ; Almazyad, Layan Tariq ; Almatrafi, Noof Daif Allah ; Almazyad, Renad Tariq ; Toraih, Eman A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g675-8467cd5d4b043e56684d28be58bd2376de075da2d9c0387159cd14965bb2ed7d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Analysis</topic><topic>Antisense RNA</topic><topic>Cancer</topic><topic>Genetic aspects</topic><topic>Ovarian cancer</topic><topic>Physiological aspects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fawzy, Manal S</creatorcontrib><creatorcontrib>Ibrahiem, Afaf T</creatorcontrib><creatorcontrib>Osman, Dalia Mohammad</creatorcontrib><creatorcontrib>Almars, Amany I</creatorcontrib><creatorcontrib>Alshammari, Maali Subhi</creatorcontrib><creatorcontrib>Almazyad, Layan Tariq</creatorcontrib><creatorcontrib>Almatrafi, Noof Daif Allah</creatorcontrib><creatorcontrib>Almazyad, Renad Tariq</creatorcontrib><creatorcontrib>Toraih, Eman A</creatorcontrib><jtitle>Epigenomes</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fawzy, Manal S</au><au>Ibrahiem, Afaf T</au><au>Osman, Dalia Mohammad</au><au>Almars, Amany I</au><au>Alshammari, Maali Subhi</au><au>Almazyad, Layan Tariq</au><au>Almatrafi, Noof Daif Allah</au><au>Almazyad, Renad Tariq</au><au>Toraih, Eman A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Angio-Long Noncoding RNA MALAT1 Gene Variants in Ovarian Cancer</atitle><jtitle>Epigenomes</jtitle><date>2024-01-01</date><risdate>2024</risdate><volume>8</volume><issue>1</issue><issn>2075-4655</issn><eissn>2075-4655</eissn><abstract>The genotyping of long non-coding RNA (lncRNA)-related single-nucleotide polymorphisms (SNPs) could be associated with cancer risk and/or progression. This study aimed to analyze the angiogenesis-related lncRNAs MALAT1 (rs3200401) and MIAT (rs1061540) variants in patients with ovarian cancer (OC) using “Real-Time allelic discrimination polymerase chain reaction” in 182 formalin-fixed paraffin-embedded (FFPE) samples of benign, borderline, and primary malignant ovarian tissues. Differences in the genotype frequencies between low-grade ovarian epithelial tumors (benign/borderline) and malignant tumors and between high-grade malignant epithelial tumors and malignant epithelial tumors other than high-grade serous carcinomas were compared. Odds ratios (ORs)/95% confidence intervals were calculated as measures of the association strength. Additionally, associations of the genotypes with the available pathological data were analyzed. The heterozygosity of MALAT1 rs3200401 was the most common genotype (47.8%), followed by C/C (36.3%). Comparing the study groups, no significant differences were observed regarding this variant. In contrast, the malignant epithelial tumors had a higher frequency of the MIAT rs1061540 C/C genotype compared to the low-grade epithelial tumor cohorts (56.7% vs. 37.6, p = 0.031). The same genotype was significantly higher in high-grade serous carcinoma than its counterparts (69.4% vs. 43.8%, p = 0.038). Multivariate Cox regression analysis showed that the age at diagnosis was significantly associated with the risk of OC development. In contrast, the MIAT T/T genotype was associated with a low risk of malignant epithelial tumors under the homozygote comparison model (OR = 0.37 (0.16–0.83), p = 0.017). Also, MIAT T allele carriers were less likely to develop high-grade serous carcinoma under heterozygote (CT vs. CC; OR = 0.33 (0.12–0.88), p = 0.027) and homozygote (TT vs. CC; OR = 0.26 (0.07–0.90), p = 0.034) comparison models. In conclusion, our data provide novel evidence for a potential association between the lncRNA MIAT rs1061540 and the malignant condition of ovarian cancer, suggesting the involvement of such lncRNAs in OC development.</abstract><pub>MDPI AG</pub><doi>10.3390/epigenomes8010005</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2075-4655 |
ispartof | Epigenomes, 2024-01, Vol.8 (1) |
issn | 2075-4655 2075-4655 |
language | eng |
recordid | cdi_gale_infotracmisc_A788246745 |
source | DOAJ Directory of Open Access Journals; PubMed Central Open Access; MDPI - Multidisciplinary Digital Publishing Institute; EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | Analysis Antisense RNA Cancer Genetic aspects Ovarian cancer Physiological aspects |
title | Angio-Long Noncoding RNA MALAT1 Gene Variants in Ovarian Cancer |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T03%3A33%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Angio-Long%20Noncoding%20RNA%20MALAT1%20Gene%20Variants%20in%20Ovarian%20Cancer&rft.jtitle=Epigenomes&rft.au=Fawzy,%20Manal%20S&rft.date=2024-01-01&rft.volume=8&rft.issue=1&rft.issn=2075-4655&rft.eissn=2075-4655&rft_id=info:doi/10.3390/epigenomes8010005&rft_dat=%3Cgale%3EA788246745%3C/gale%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A788246745&rfr_iscdi=true |